Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Larsen

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Thrombosis Research|June 15, 1988
Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)P M Sandset, U Abildgaard, M L Larsen
Ugeskrift for Laeger|May 18, 1987
[Menstrual pattern and metabolic control in women 18 to 40-years old with diabetes mellitus]L E Matzen, M L Larsen, K Dinsen
Acta Paediatrica Scandinavica|July 1, 1988
Heparin cofactor II, antithrombin and protein C in plasma from term and preterm infantsT R Andersson, H Bangstad, M L Larsen
Thrombosis Research|July 15, 1987
Low heparin cofactor II associated with abnormal crossed immunoelectrophoresis pattern in two Norwegian familiesT R Andersson, M L Larsen, U Abildgaard
Scandinavian Journal of Infectious Diseases|January 1, 1988
Acyclovir crystalluriaN A Peterslund, M L Larsen, H Mygind
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1990
The influence of induced hyperglycaemia on gastric emptying rate in healthy humansE Oster-Jørgensen, S A Pedersen, M L Larsen
Clinical Chemistry|September 1, 1990
Setting analytical goals for random analytical error in specific clinical monitoring situationsC G Fraser, P Hyltoft Peterson, M L Larsen
Upsala Journal of Medical Sciences|January 1, 1993
Quality specifications for haemoglobin A1c assays in the monitoring of diabetesM L Larsen, P H Petersen, C G Fraser
Annals of Clinical Biochemistry|May 1, 1991
A comparison of analytical goals for haemoglobin A1c assays derived using different strategiesM L Larsen, C G Fraser, P H Petersen
Atherosclerosis|April 1, 1994
Comparative effects of gemfibrozil and clofibrate in type III hyperlipoproteinemiaM L Larsen, D R Illingworth, J P O'Malley
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Thrombosis Research|June 15, 1988
Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)P M Sandset, U Abildgaard, M L Larsen
Ugeskrift for Laeger|May 18, 1987
[Menstrual pattern and metabolic control in women 18 to 40-years old with diabetes mellitus]L E Matzen, M L Larsen, K Dinsen
Acta Paediatrica Scandinavica|July 1, 1988
Heparin cofactor II, antithrombin and protein C in plasma from term and preterm infantsT R Andersson, H Bangstad, M L Larsen
Thrombosis Research|July 15, 1987
Low heparin cofactor II associated with abnormal crossed immunoelectrophoresis pattern in two Norwegian familiesT R Andersson, M L Larsen, U Abildgaard
Scandinavian Journal of Infectious Diseases|January 1, 1988
Acyclovir crystalluriaN A Peterslund, M L Larsen, H Mygind
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1990
The influence of induced hyperglycaemia on gastric emptying rate in healthy humansE Oster-Jørgensen, S A Pedersen, M L Larsen
Clinical Chemistry|September 1, 1990
Setting analytical goals for random analytical error in specific clinical monitoring situationsC G Fraser, P Hyltoft Peterson, M L Larsen
Upsala Journal of Medical Sciences|January 1, 1993
Quality specifications for haemoglobin A1c assays in the monitoring of diabetesM L Larsen, P H Petersen, C G Fraser
Annals of Clinical Biochemistry|May 1, 1991
A comparison of analytical goals for haemoglobin A1c assays derived using different strategiesM L Larsen, C G Fraser, P H Petersen
Atherosclerosis|April 1, 1994
Comparative effects of gemfibrozil and clofibrate in type III hyperlipoproteinemiaM L Larsen, D R Illingworth, J P O'Malley
Pageof 8